Hypermarcas (OTCMKTS:HYPMY – Get Free Report) and Trulieve Cannabis (NYSE:TRLV – Get Free Report) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.
Analyst Recommendations
This is a breakdown of current ratings and target prices for Hypermarcas and Trulieve Cannabis, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Hypermarcas | 0 | 1 | 0 | 1 | 3.00 |
| Trulieve Cannabis | 1 | 1 | 1 | 0 | 2.00 |
Trulieve Cannabis has a consensus target price of $15.00, indicating a potential upside of 31.71%. Given Trulieve Cannabis’ higher possible upside, analysts plainly believe Trulieve Cannabis is more favorable than Hypermarcas.
Earnings and Valuation
This table compares Hypermarcas and Trulieve Cannabis”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Hypermarcas | $1.38 billion | 2.07 | $213.10 million | $0.50 | 8.12 |
| Trulieve Cannabis | $1.08 billion | 2.03 | -$116.38 million | $0.20 | 56.94 |
Hypermarcas has higher revenue and earnings than Trulieve Cannabis. Hypermarcas is trading at a lower price-to-earnings ratio than Trulieve Cannabis, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Hypermarcas and Trulieve Cannabis’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Hypermarcas | 19.77% | 12.68% | 6.78% |
| Trulieve Cannabis | -41.22% | -0.34% | -0.14% |
Summary
Hypermarcas beats Trulieve Cannabis on 9 of the 12 factors compared between the two stocks.
About Hypermarcas
Hypermarcas was a Brazilian consumer-products and pharmaceutical company that later adopted the name Hypera Pharma. The company refocused its operations on pharmaceuticals after divesting a number of businesses in other consumer-goods categories. Today, Hypera Pharma develops, manufactures and markets medicines in Brazil, including prescription drugs, over-the-counter products and branded generics. Its portfolio also includes vitamins and supplements, and it sells products under brands such as Neo Química and Mantecorp.
About Trulieve Cannabis
Trulieve Cannabis Corp. is a U.S. cannabis company that cultivates, processes and sells cannabis products through a vertically integrated business. Its offerings include flower, concentrates, vape products, edibles and other cannabis products, sold under brands such as Trulieve and Modern Flower. Founded in Florida in 2015, the company built its business in that state and expanded into other U.S. markets, including Arizona and Pennsylvania. Its operations and product offerings are shaped by the regulations in each state where it operates.
Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.
